Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Berczi

Showing results (41-50 of 86) with videos related to

Pageof 9
Sort By:
Acta Endocrinologica|March 1, 1983
Regulation of immunity in rats by lactogenic and growth hormonesE Nagy, I Berczi, H G Friesen
Immunology|February 1, 1982
Tumour cell-antibody interactions. I. In vivo experimentsG Froese, I Berczi, L G Israels
Annals of the New York Academy of Sciences|March 28, 2001
Natural immunity and neuroimmune host defenseI Berczi, L Bertók, D A Chow
Cancer Immunology, Immunotherapy : CII|January 1, 1991
Growth inhibition of murine mammary carcinoma by monoclonal IgE antibodies specific for the mammary tumor virusE Nagy, I Berczi, A H Sehon
Immunochemistry|April 1, 1976
Characterization of the target cell receptor for IgE-I. Solubilization of IgE-receptor complexes from rat mast cells and rat basophilic leukemia cellsD H Conrad, I Berczi, A Froese
Brain, Behavior, and Immunity|June 1, 1992
Neuro-hormonal host defence in endotoxin shockR N Ramachandra, A H Sehon, I Berczi
Domestic Animal Endocrinology|October 24, 1998
Neuroimmunoregulation and natural immunityI Berczi, D A Chow, E R Sabbadini
Anticancer Research|January 1, 1997
Immunotherapy of the SL2-5 murine lymphoma with natural killer cells and tamoxifen or toremifeneE Baral, E Nagy, L Kangas, et al.
Anticancer Research|December 31, 1997
Combination therapy of the H2712 murine mammary carcinoma with cytotoxic T lymphocytes and anti-estrogensE Baral, E Nagy, L Kangas, et al.
International Journal of Cancer|August 7, 1996
Anti-estrogens enhance the therapeutic effect of lymphokine-activated killer cells on the P815 murine mastocytomaE Baral, E Nagy, L Kangas, et al.
Pageof 9

Showing results (41-50 of 86) with videos related to

Sort By:
Pageof 9
Acta Endocrinologica|March 1, 1983
Regulation of immunity in rats by lactogenic and growth hormonesE Nagy, I Berczi, H G Friesen
Immunology|February 1, 1982
Tumour cell-antibody interactions. I. In vivo experimentsG Froese, I Berczi, L G Israels
Annals of the New York Academy of Sciences|March 28, 2001
Natural immunity and neuroimmune host defenseI Berczi, L Bertók, D A Chow
Cancer Immunology, Immunotherapy : CII|January 1, 1991
Growth inhibition of murine mammary carcinoma by monoclonal IgE antibodies specific for the mammary tumor virusE Nagy, I Berczi, A H Sehon
Immunochemistry|April 1, 1976
Characterization of the target cell receptor for IgE-I. Solubilization of IgE-receptor complexes from rat mast cells and rat basophilic leukemia cellsD H Conrad, I Berczi, A Froese
Brain, Behavior, and Immunity|June 1, 1992
Neuro-hormonal host defence in endotoxin shockR N Ramachandra, A H Sehon, I Berczi
Domestic Animal Endocrinology|October 24, 1998
Neuroimmunoregulation and natural immunityI Berczi, D A Chow, E R Sabbadini
Anticancer Research|January 1, 1997
Immunotherapy of the SL2-5 murine lymphoma with natural killer cells and tamoxifen or toremifeneE Baral, E Nagy, L Kangas, et al.
Anticancer Research|December 31, 1997
Combination therapy of the H2712 murine mammary carcinoma with cytotoxic T lymphocytes and anti-estrogensE Baral, E Nagy, L Kangas, et al.
International Journal of Cancer|August 7, 1996
Anti-estrogens enhance the therapeutic effect of lymphokine-activated killer cells on the P815 murine mastocytomaE Baral, E Nagy, L Kangas, et al.
Pageof 9